Emily Peterson Alva sold $712K of Amneal Pharmaceuticals (AMRX)

Executed Mar 5 2025, disclosed Mar 7 2025, 2 days later.

Value, as filed

$712K

80,000 sh × $8.90

Executed

Mar 5 2025

the trade date, as filed

Disclosed

Mar 7 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

EA Emily Peterson Alva Director profile →

Emily Peterson Alva (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Amneal Pharmaceuticals, Inc. (AMRX). The largest single filing was $712K of AMRX (80,000 sh × $8.90, as filed), executed Mar 5 2025.

The name

AMRX Amneal Pharmaceuticals, Inc. AMRX · Healthcare · 32 filings in 24 months ticker →

Healthcare · Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, b…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→